289
Views
16
CrossRef citations to date
0
Altmetric
Review

Proteomics in prostate cancer biomarker discovery

, , , , , & show all
Pages 93-102 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shanchun Guo, Jin Zou & Guangdi Wang. (2013) Advances in the proteomic discovery of novel therapeutic targets in cancer. Drug Design, Development and Therapy 7, pages 1259-1271.
Read now

Articles from other publishers (15)

Mohd Mabood Khan, Vineeta Sharma & Mohammad Serajuddin. (2023) Emerging role of miRNA in prostate cancer: A future era of diagnostic and therapeutics. Gene 888, pages 147761.
Crossref
Matteo Capaia, Ilaria Granata, Mario Guarracino, Andrea Petretto, Elvira Inglese, Carlo Cattrini, Nicoletta Ferrari, Francesco Boccardo & Paola Barboro. (2018) A hnRNP K–AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences 19:7, pages 1920.
Crossref
Henry A. Adeola, Jonathan M. Blackburn, Timothy R. Rebbeck & Luiz F. Zerbini. (2017) Emerging proteomics biomarkers and prostate cancer burden in Africa. Oncotarget 8:23, pages 37991-38007.
Crossref
Katarina Davalieva & Momir Polenakovic. (2015) Proteomics in Diagnosis of Prostate Cancer/ Протеомика Во Дијагноза На Простатниот Карцином. PRILOZI 36:1, pages 5-36.
Crossref
Pier Giorgio Righetti, Giovanni Candiano, Attilio Citterio & Egisto Boschetti. (2014) Combinatorial Peptide Ligand Libraries as a “Trojan Horse” in Deep Discovery Proteomics. Analytical Chemistry 87:1, pages 293-305.
Crossref
Ruth Anna Fuhrman‐Luck, Munasinghage Lakmali Silva, Ying Dong, Helen Irving‐Rodgers, Thomas Stoll, Marcus Lachlan Hastie, Daniela Loessner, Jeffrey John Gorman & Judith Ann Clements. (2014) Proteomic and other analyses to determine the functional consequences of deregulated kallikrein‐related peptidase ( KLK ) expression in prostate and ovarian cancer . PROTEOMICS – Clinical Applications 8:5-6, pages 403-415.
Crossref
Stefania Bergamini, Elisa Bellei, Luca Reggiani Bonetti, Emanuela Monari, Aurora Cuoghi, Francesco Borelli, Maria Sighinolfi, Giampaolo Bianchi, Tomris Ozben & Aldo Tomasi. (2014) Inflammation: an important parameter in the search of prostate cancer biomarkers. Proteome Science 12:1, pages 32.
Crossref
Galina Botchkina. (2013) Colon cancer stem cells – From basic to clinical application. Cancer Letters 338:1, pages 127-140.
Crossref
Chenchen Zhang, Zheng Liu, Xi Liu, Lan Wei, Yanjie Liu, Jing Yu & Lixin Sun. (2013) Targeted metabolic analysis of nucleotides and identification of biomarkers associated with cancer in cultured cell models. Acta Pharmaceutica Sinica B 3:4, pages 254-262.
Crossref
Ai-hua Zhang, Hui Sun, Guang-li Yan, Ying Han & Xi-jun Wang. (2013) Serum Proteomics in Biomedical Research: A Systematic Review. Applied Biochemistry and Biotechnology 170:4, pages 774-786.
Crossref
. 2013. Low-Abundance Proteome Discovery. Low-Abundance Proteome Discovery 323 332 .
Yong Zhang, Bin Guo & Ran Bi. (2012) Ovarian Cancer: Biomarker Proteomic Diagnosis in Progress. Applied Biochemistry and Biotechnology 168:4, pages 910-916.
Crossref
Anne K. Callesen, Ole Mogensen, Andreas K. Jensen, Torben A. Kruse, Torben Martinussen, Ole N. Jensen & Jonna S. Madsen. (2012) Reproducibility of mass spectrometry based protein profiles for diagnosis of ovarian cancer across clinical studies: A systematic review. Journal of Proteomics 75:10, pages 2758-2772.
Crossref
Zeyu Xiao, Etgar Levy-Nissenbaum, Frank Alexis, Andrej Lupták, Benjamin A. Teply, Juliana M. ChanJinjun Shi, Elise Digga, Judy Cheng, Robert Langer & Omid C. Farokhzad. (2012) Engineering of Targeted Nanoparticles for Cancer Therapy Using Internalizing Aptamers Isolated by Cell-Uptake Selection. ACS Nano 6:1, pages 696-704.
Crossref
Grigoriy Blekherman, Reinhard Laubenbacher, Diego F. Cortes, Pedro Mendes, Frank M. Torti, Steven Akman, Suzy V. Torti & Vladimir Shulaev. (2011) Bioinformatics tools for cancer metabolomics. Metabolomics 7:3, pages 329-343.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.